Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Antibiotic-like producing bacteria in human breast milk modifies the infant’s oral and gut microbiomes to suppress the growth of harmful bacteria.
FY 2022-23
Summary
Breast milk provides important nutrition and immune support for a growing infant. It is a reservoir of many essential bioactive components that protect infants from infectious and chronic diseases. Breast milk also contains a network of different beneficial microorganisms collectively known as the breast milk microbiome.
One of the most abundant “friendly” microbes found in human breast milk is Staphylococcus epidermidis, a common human-associated bacterium that secretes small antimicrobial peptides called bacteriocins. These small inhibitory molecules can prevent the growth of invading pathogens, including the antibiotic-resistant Staphylococcus aureus superbugs. Moreover, studies have shown a strong correlation between the breast milk microbiome and the development of the infant’s gut microbiome; however, the mechanism by which breastfeeding modulates the composition of gut bacteria is poorly understood. Based on their potent antimicrobial activities, we hypothesize that bacteriocins secreted into the breast milk may play an important role in modifying the infant’s oral and gut microbiome to suppress the colonization of harmful bacteria and promote healthy human microbiomes. In this study, we will identify and characterize unique bacteriocins from mothers’ milk using molecular and proteomics techniques and correlate the secretion of these antimicrobial molecules with the development of oral and gut microbiomes of breastfed infants. Identifying useful antibacterial molecules in human breast milk as key modulators of the infant microbiome will contribute significantly to the understanding of the protection mechanisms carried out by the breast milk microbiome and guide the development of novel therapeutics to fight infectious diseases.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
486079
Name
Marks Cara
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Antibiotic-like producing bacteria in human breast milk modifies the infant’s oral and gut microbiomes to suppress the growth of harmful bacteria.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antibiotic-Like Substances; Commensal Bacteria; Human Breast Milk Microbiome; Infant Gut And Oral Microbiomes; Infant Health; Novel Antimicrobial Therapeutics; Prevention Of Infectious Disease
Abstract
Breast milk provides important nutrition and immune support for a growing infant. It is a reservoir of many essential bioactive components that protect infants from infectious and chronic diseases. Breast milk also contains a network of different beneficial microorganisms collectively known as the breast milk microbiome.
One of the most abundant “friendly” microbes found in human breast milk is Staphylococcus epidermidis, a common human-associated bacterium that secretes small antimicrobial peptides called bacteriocins. These small inhibitory molecules can prevent the growth of invading pathogens, including the antibiotic-resistant Staphylococcus aureus superbugs. Moreover, studies have shown a strong correlation between the breast milk microbiome and the development of the infant’s gut microbiome; however, the mechanism by which breastfeeding modulates the composition of gut bacteria is poorly understood. Based on their potent antimicrobial activities, we hypothesize that bacteriocins secreted into the breast milk may play an important role in modifying the infant’s oral and gut microbiome to suppress the colonization of harmful bacteria and promote healthy human microbiomes. In this study, we will identify and characterize unique bacteriocins from mothers’ milk using molecular and proteomics techniques and correlate the secretion of these antimicrobial molecules with the development of oral and gut microbiomes of breastfed infants. Identifying useful antibacterial molecules in human breast milk as key modulators of the infant microbiome will contribute significantly to the understanding of the protection mechanisms carried out by the breast milk microbiome and guide the development of novel therapeutics to fight infectious diseases.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Marks, Cara
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~